About Nonacus
Nonacus is a company based in Birmingham (United Kingdom) founded in 2015. It operates as a B2B. The company has 13 employees as of December 31, 2020. Nonacus offers products and services including GALEAS Tumor Test, cfDNA Extraction Kit, Panel Design Tool, and GALEAS Hereditary Plus Test. Nonacus operates in a competitive market with competitors including Natera, Arbor Biotechnologies, Singleron, Tessera Therapeutics and Phase Genomics, among others.
- Headquarter Birmingham, United Kingdom
- Employees 13 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nonacus Limited
- Date of Incorporation 14 May, 2015
- Jurisdiction BIRMINGHAM, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
13
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nonacus
Nonacus offers a comprehensive portfolio of products and services, including GALEAS Tumor Test, cfDNA Extraction Kit, Panel Design Tool, and GALEAS Hereditary Plus Test.
NGS-based test for detecting tumor variants in clinical research
Kit for efficient cell-free DNA extraction from samples
Platform for creating custom NGS panels quickly
Test for hereditary genetic mutations using NGS
People of Nonacus
Unlock access to complete
Unlock access to complete
Funding Insights of Nonacus
Detailed funding history for Nonacus
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nonacus
Investment portfolio details for Nonacus
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nonacus
Detailed financials for Nonacus
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nonacus Comparisons
Peer comparison for Nonacus
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nonacus
Nonacus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, Arbor Biotechnologies, Singleron, Tessera Therapeutics and Phase Genomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Genomic technologies and drug discovery platforms are provided.
|
|
| Locked | Locked | Locked |
Developer of single-cell multi-omics platform for clinical research and molecular diagnosis
|
|
| Locked | Locked | Locked |
New genome engineering technology is provided for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Laboratory and computational services for DNA proximity analysis are provided.
|
|
| Locked | Locked | Locked |
Provider of medical diagnosis and clinical laboratory analysis services
|
Detailed competitors of Nonacus
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nonacus
Complete news archive for Nonacus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nonacus
Nonacus was founded in 2015.
Nonacus is headquartered in Birmingham, United Kingdom. It is registered at Birmingham, England, United Kingdom.
As of Dec 31, 2020, the latest employee count at Nonacus is 13.
Nonacus specializes in liquid biopsy and NGS technologies, offering end-to-end workflows for sample collection, DNA extraction, and testing in oncology and germline genetics. The company designs customizable panels for detecting mutations and chromosomal abnormalities, supporting research and clinical applications. Based in Birmingham, United Kingdom, it serves laboratories, distributors, and professionals in precision medicine through innovative biotechnology tools.
Nonacus's top competitors include Natera, Tessera Therapeutics and Arbor Biotechnologies.
Nonacus offers GALEAS Tumor Test, cfDNA Extraction Kit, Panel Design Tool, and GALEAS Hereditary Plus Test.